Top Markets
Coin of the day
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.

China BCT Pharmacy Group, Inc.

CNBI
株式のランク #42162
China BCT Pharmacy Group, Inc. functions as a comprehensive pharmaceutical... China BCT Pharmacy Group, Inc. functions as a comprehensive pharmaceutical enterprise within the People's Republic of China, conducting its operations through various subsidiary companies. Its business activities are primarily categorized into three distinct divisions: Pharmaceutical Distribution, Retail Pharmacy, and Pharmaceutical Manufacturing. The Pharmaceutical Distribution division procures a diverse array of medicinal goods from various suppliers, subsequently supplying them to a broad client base that includes hospitals, retail drug stores, other wholesale distributors, clinics, medical centers, and individual consumers. Its extensive inventory, numbering approximately 8,000 distinct items, encompasses both branded and generic prescription medications, over-the-counter remedies, traditional Western and Chinese medicines, personal care products, medical supplies, Chinese herbal remedies, and medical instruments. Through its Retail Pharmacy segment, the company manages a network of 196 directly owned pharmacies, predominantly located in Guangxi province, operating under the "Baicaotang" brand. These outlets provide expert pharmaceutical services and offer a broad assortment of health-related products. This range includes prescription and non-prescription drugs, refined and roughly processed traditional Chinese herbal medicines, family planning items, and various other pharmaceutical and healthcare products. The Pharmaceutical Manufacturing division, operating under the "Asio" brand, is responsible for producing and marketing a range of generic and clinical pharmaceuticals. This includes treatments for inflammation and bacterial infections, oncology drugs, cardiovascular medications, and hepatitis therapies. Key products manufactured by the company include Levodopa, Tabellae Sarcandrae, Rotandine Sulfate, Corydalis Saxicola Bunting, and Ethacridine Lactate injection. The company was originally known as China Baicaotang Medicine Limited before adopting its current name, China BCT Pharmacy Group, Inc., in March 2010. Its corporate headquarters are situated in Liuzhou, People's Republic of China.
株価
$0.0001
最終同期: 2025-06-02
時価総額
$3.82K
変化(1日)
0.00%
変化(1年)
0.00%
CN
取引 China BCT Pharmacy Group, Inc. (CNBI)

カテゴリー

Bの時価総額のCNBIの価格
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
CNBI
$0.0001
の時価総額 China BCT Pharmacy Group, Inc.(CNBI)
時価総額: $3.82K
August 2026時点で、China BCT Pharmacy Group, Inc. の時価総額は $3.82K です。これは、当社のデータによると、China BCT Pharmacy Group, Inc. が世界で42162nd番目に価値のある企業であることを意味します。時価総額は、上場企業の発行済株式の総市場価値であり、企業の価値を測るためによく使用されます。
China BCT Pharmacy Group, Inc. の時価総額の履歴(2010 から 2026 まで)
CNBI最も人気のあるトップ5と比較stocks
CNBIの価格 資産b bの市場 結果
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
$141,094 $3.82K
$5.383T +141,094,292,751.11%
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
$115,934 $3.82K
$4.423T +115,934,159,328.25%
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
$109,041 $3.82K
$4.160T +109,040,531,695.15%
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
$96,013.21 $3.82K
$3.663T +96,013,217,450.08%
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
$75,777.19 $3.82K
$2.891T +75,777,195,420.53%